ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/10/30 | 3,020 | 3,135 | 2,993 | 3,050 | +30 | +1% | 867,300 |
2024/10/29 | 2,962 | 3,030 | 2,945 | 3,020 | +58 | +2% | 812,400 |
2024/10/28 | 2,802 | 2,962 | 2,800 | 2,962 | +163 | +5.8% | 1,074,800 |
2024/10/25 | 2,755 | 2,819 | 2,731 | 2,799 | ±0 | ±0% | 999,400 |
2024/10/24 | 2,861 | 2,875 | 2,751 | 2,799 | -101 | -3.5% | 1,445,600 |
2024/10/23 | 3,005 | 3,060 | 2,875 | 2,900 | -80 | -2.7% | 1,343,000 |
2024/10/22 | 3,005 | 3,005 | 2,918 | 2,980 | -70 | -2.3% | 1,099,900 |
2024/10/21 | 2,918 | 3,065 | 2,910 | 3,050 | +108 | +3.7% | 830,500 |
2024/10/18 | 2,952 | 2,982 | 2,902 | 2,942 | -28 | -0.9% | 622,100 |
2024/10/17 | 2,977 | 3,045 | 2,941 | 2,970 | -4 | -0.1% | 985,000 |
2024/10/16 | 2,860 | 2,986 | 2,835 | 2,974 | +87 | +3% | 780,200 |
2024/10/15 | 2,897 | 2,925 | 2,825 | 2,887 | +30 | +1.1% | 824,600 |
2024/10/11 | 2,840 | 2,878 | 2,818 | 2,857 | +4 | +0.1% | 623,700 |
2024/10/10 | 2,918 | 2,928 | 2,842 | 2,853 | -83 | -2.8% | 1,025,400 |
2024/10/09 | 2,966 | 3,095 | 2,925 | 2,936 | +20 | +0.7% | 1,665,600 |
2024/10/08 | 2,951 | 2,999 | 2,871 | 2,916 | -46 | -1.6% | 1,040,100 |
2024/10/07 | 2,900 | 2,978 | 2,856 | 2,962 | +112 | +3.9% | 1,176,800 |
2024/10/04 | 2,891 | 2,913 | 2,802 | 2,850 | -64 | -2.2% | 1,248,200 |
2024/10/03 | 2,954 | 2,968 | 2,832 | 2,914 | +39 | +1.4% | 1,606,700 |
2024/10/02 | 2,965 | 3,010 | 2,857 | 2,875 | -160 | -5.3% | 1,688,400 |
2024/10/01 | 2,915 | 3,120 | 2,836 | 3,035 | +148 | +5.1% | 1,991,700 |
2024/09/30 | 2,927 | 2,952 | 2,880 | 2,887 | -90 | -3% | 1,838,400 |
2024/09/27 | 2,860 | 3,005 | 2,851 | 2,977 | +116 | +4.1% | 1,943,200 |
2024/09/26 | 2,785 | 2,872 | 2,742 | 2,861 | +83 | +3% | 1,464,900 |
2024/09/25 | 2,701 | 2,793 | 2,698 | 2,778 | +55 | +2% | 1,152,300 |
2024/09/24 | 2,754 | 2,796 | 2,706 | 2,723 | -13 | -0.5% | 1,641,200 |
2024/09/20 | 2,682 | 2,760 | 2,640 | 2,736 | +98 | +3.7% | 2,104,100 |
2024/09/19 | 2,531 | 2,665 | 2,497 | 2,638 | +145 | +5.8% | 2,385,700 |
2024/09/18 | 2,475 | 2,497 | 2,375 | 2,493 | +58 | +2.4% | 1,328,900 |
2024/09/17 | 2,499 | 2,531 | 2,349 | 2,435 | -60 | -2.4% | 1,778,800 |
2024/09/13 | 2,455 | 2,571 | 2,405 | 2,495 | +232 | +10.3% | 4,486,100 |
2024/09/12 | 2,218 | 2,284 | 2,193 | 2,263 | +120 | +5.6% | 1,366,500 |
2024/09/11 | 2,228 | 2,237 | 2,111 | 2,143 | -84 | -3.8% | 1,129,900 |
2024/09/10 | 2,149 | 2,260 | 2,114 | 2,227 | +111 | +5.2% | 926,100 |
2024/09/09 | 2,016 | 2,151 | 2,001 | 2,116 | +21 | +1% | 1,147,900 |
2024/09/06 | 2,140 | 2,148 | 2,078 | 2,095 | -47 | -2.2% | 861,100 |
2024/09/05 | 2,058 | 2,160 | 2,058 | 2,142 | +60 | +2.9% | 1,191,400 |
2024/09/04 | 2,097 | 2,141 | 2,042 | 2,082 | -148 | -6.6% | 1,772,800 |
2024/09/03 | 2,245 | 2,299 | 2,171 | 2,230 | -17 | -0.8% | 1,422,800 |
2024/09/02 | 2,320 | 2,333 | 2,238 | 2,247 | -42 | -1.8% | 1,369,400 |
2024/08/30 | 2,331 | 2,358 | 2,239 | 2,289 | -46 | -2% | 1,989,100 |
2024/08/29 | 2,250 | 2,449 | 2,184 | 2,335 | +95 | +4.2% | 4,058,600 |
2024/08/28 | 2,379 | 2,420 | 2,202 | 2,240 | -206 | -8.4% | 3,462,900 |
2024/08/27 | 2,240 | 2,459 | 2,202 | 2,446 | +205 | +9.1% | 3,479,600 |
2024/08/26 | 2,153 | 2,288 | 2,094 | 2,241 | +318 | +16.5% | 3,902,900 |
2024/08/23 | 1,818 | 1,924 | 1,816 | 1,923 | +94 | +5.1% | 801,800 |
2024/08/22 | 1,870 | 1,878 | 1,813 | 1,829 | -16 | -0.9% | 621,200 |
2024/08/21 | 1,834 | 1,879 | 1,810 | 1,845 | -29 | -1.5% | 748,800 |
2024/08/20 | 1,914 | 1,914 | 1,831 | 1,874 | +18 | +1% | 889,600 |
2024/08/19 | 1,870 | 1,960 | 1,834 | 1,856 | +6 | +0.3% | 1,513,600 |
151~
200
件表示中 / 3720件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 382,000円 | +21.7% | +999.9% | 0.00% | 16.01倍 | 5.29倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
サワイGHD | 181,600円 | +5.9% | +684.6% | 3.03% | 12.05倍 | 1.21倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
キッセイ薬 | 420,000円 | +3.6% | +6.1% | 2.86% | 14.15倍 | 0.83倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 386,700円 | -6.4% | -71.8% | 4.91% | 43.06倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム